Page 1365 - Small Animal Internal Medicine, 6th Edition
P. 1365

CHAPTER 81   Selected Neoplasms in Dogs and Cats   1337


            Lester S, et al. Vaccine-site associated sarcomas in cats: clinical   Shaw SC, et al. Temporal changes in characteristics of injection-site
              experience and a laboratory review (1982-1993).  J Am  Anim   sarcomas in cats: 392 cases (1990-2006). J Am Vet Med Assoc.
  VetBooks.ir  Phelps HA, et al. Radical excision with five-centimeter margins for   Shrivastav A, et al. Comparative vaccine-specific and other
              Hosp Assoc. 1996;32:91.
                                                                  2009;234:376.
              treatment of feline injection-site sarcomas: 91 cases (1998-2002).
                                                                  injectable-specific risks of injection-site sarcomas in cats. J Am
              J Am Vet Med Assoc. 2011;239:97.                    Vet Med Assoc. 2012;241:595.
            Romanelli G, et al. Analysis of prognostic factors associated with   Wilcock B, et al. Feline postvaccinal sarcomas: 20 years later. Can
              injection-site sarcomas in cats: 57 cases (2001-2007). J Am Vet   Vet J. 2012;53:430.
              Med Assoc. 2008;232:1193.
            Scherk MA, et al. AAFP feline vaccination advisory panel report. J
              Feline Med Surg. 2013;15(785):2013.



            Cancer Chemotherapy Protocols Commonly Used by the Authors

             1. Lymphoma
                 A. Induction of remission
                  1. COP protocol (8-week duration)
                                            2
                    Cyclophosphamide: 50 mg/m  PO q48h for 8 weeks in dogs; 200-300 mg/m  PO q3 weeks in cats
                                                                                   2
                                      2
                    Vincristine: 0.5 mg/m  IV once per week for 8 weeks
                                        2
                                                                          2
                    Prednisone: 40-50 mg/m  PO q24h for 1 week; then 20-25 mg/m  PO q48h for 7 weeks
                  2. COAP protocol
                                            2
                    Cyclophosphamide: 50 mg/m  PO q48h or 300 mg/m  PO q3 weeks*
                                                                 2
                    Vincristine: 0.5 mg/m  IV once per week
                                      2
                                               2
                    Cytosine arabinoside: 100 mg/m , IV or SC, divided q12h for 4 days
                                                                          2
                    Prednisone: 40-50 mg/m  PO q24h for 1 week; then 20-25 mg/m  PO q48h
                                        2
                    In cats, cytosine arabinoside is administered for only 2 days and the remaining three drugs (cyclophosphamide,
                       vincristine, prednisone) are administered for 6 weeks rather than 8 weeks.
                  3. CLOP protocol
                    As in COP protocol but with the addition of L-asparaginase at a dosage of 10,000-20,000 IU/m  IM q4-6 weeks
                                                                                                 2
                  4. UW-25 protocol (This protocol uses no maintenance chemotherapy—for additional information please see text)
                    Week 1:  Vincristine: 0.5-0.75 mg/m  IV
                                                   2
                             Prednisone: 40 mg/m  PO q24h
                                               2
                    Week 2:  Cyclophosphamide: 200-250 mg/m , IV or PO
                                                          2
                             Prednisone: 30 mg/m  PO q24h
                                               2
                                                   2
                    Week 3:  Vincristine: 0.5-0.75 mg/m  IV
                                               2
                             Prednisone: 20 mg/m  PO q24h
                                               2
                    Week 4:  Doxorubicin: 30 mg/m  (or 1 mg/kg if < 10 kg) IV
                                               2
                             Prednisone: 10 mg/m  PO q24h
                    Week 5:  No treatment—discontinue prednisone if CR
                    Week 6:  Vincristine: 0.5-0.75 mg/m  IV
                                                   2
                    Week 7:  Cyclophosphamide: 200-250 mg/m , IV or PO
                                                          2
                                                   2
                    Week 8:  Vincristine: 0.5-0.75 mg/m  IV
                                               2
                    Week 9:  Doxorubicin: 30 mg/m  (or 1 mg/kg if < 10 kg) IV
                    Week 10:  No treatment
                    Week 11:  Vincristine: 0.5-0.75 mg/m  IV
                                                   2
                                                          2
                    Week 13:  Cyclophosphamide: 200-250 mg/m , IV or PO
                                                   2
                    Week 15:  Vincristine: 0.5-0.75 mg/m  IV
                    Week 17:  Doxorubicin: 30 mg/m  (or 1 mg/kg if < 10 kg) IV
                                               2
                    Week 18:  No treatment
                    Week 19:  Vincristine: 0.5-0.75 mg/m  IV
                                                   2
                                                          2
                    Week 21:  Cyclophosphamide: 200-250 mg/m , IV or PO
                    Week 23:  Vincristine: 0.5-0.75 mg/m  IV
                                                   2
                    Week 25:  Doxorubicin: 30 mg/m  (or 1 mg/kg if < 10 kg) IV
                                               2
                B. Maintenance
                  1. LMP protocol
                    Chlorambucil: 20 mg/m  PO q2 weeks
                                       2
                                        2
                    Prednisone: 20-25 mg/m  PO q48h
                                         2
                    Methotrexate: 2.5-5 mg/m  PO 2 or 3 times per week
                                                                                                          Continued
   1360   1361   1362   1363   1364   1365   1366   1367   1368   1369   1370